Trivarx Ltd has released a press release.
Strategic Plan for FDA and CE Mark Approval
Filed with ASX ·
6ix hasn’t read this filing yet.
Earlier from TrivarX
- Company Update
- Results of Annual General Meeting
- Pause in Trading
- Medibio Signs Agreement with PwC Australia for ilumen
- MEB successfully completes first Ilumen pilot with Compass
Later from TrivarX
- Final Compass Pilot Completed Successfully
- Medibio submits FDA 510K Application to FDA
- Placement and Fully Underwritten Entitlement Offer
- Entitlement Offer Booklet
- Entitlement Issue Results
Follow TrivarX into a list and get an email when it puts out news.
Follow TrivarX